Bachelor of Medicine (University of the Witwatersrand, Johannesburg), Master of Public Health – Health Policy and Health Economics (Johns Hopkins University, Baltimore)
Caroline Popper is a US-based pathologist and business consultant, with more than 20 years’ operational experience in the international diagnostics, medical devices and drug discovery fields. After 10 years in senior management and marketing roles at Becton, Dickinson and Company, Caroline established her own consultancy company to provide strategic corporate and advisory services to businesses across the life sciences spectrum.
A qualified health economist, Caroline has served in senior managerial and advisory positions at a number of global diagnostics and medical research companies, including bioMérieux and MDS Proteomics, where she was Chief Business Officer from 2000 to 2002. As well as extensive corporate experience, Caroline enjoys a hands-on clinical perspective from her years as an attending physician at the Department of Emergency Medicine at Baltimore’s Johns Hopkins Hospital, where she completed residencies in internal medicine and pathology.
In 2003, Caroline founded Popper and Company, a strategy and M&A advisory firm focused on diagnostics, medical devices, life science tools, and wireless health applications. Her other directorships include Innovative Biosensors Inc (Chairman), nanoMR, Rarecyte and Pilgrim Software Inc.
Commencement date: 15/03/2012
Chief Executive Officer and Managing Director
Master of Project Management (University of Adelaide), Diploma of Commerce (Sydney Institute of Business and Technology), Graduate, Australian Institute Of Company Directors (Australian Institute Of Company Directors).
After launching his career with global defence contractor Thales, Brent Barnes spent 11 years in a range of senior executive roles with the pioneering Australian medical device manufacturer, Cochlear Limited. Having led an important transformation project within Cochlear’s Global Quality and Regulatory Group, Brent worked for Cochlear Americas in the United States, where he held senior operations and sales roles based in Colorado and Texas. During this time he established a US manufacturing subsidiary from the ground up, where product was manufactured and business audited by the FDA with no observations. After four years in the US, Brent relocated to Sydney and Singapore Cochlear offices as Director Asia Growth Markets & Operations, Asia Pacific.
Brent is also a non-executive director of Connek Pty Ltd, a telecommunications and IT professional services company that sub-contracts specialist services to leading blue chip telecommunications companies working on the rollout of Australia’s National Broadband Network.
In his spare time, he enjoys a broad array of sports and tries to keep fit. A keen Aussie Rules follower, Brent is a life member of Sydney’s North Shore Bombers and, during his US posting, he played Australian Rules football for the Denver Bulldogs.
Commencement date: 08/08/2016
Law Degree (University of Melbourne)
Kate Costello was in management with a commercial law firm before establishing Governance Matters, a management consultancy firm specialising in corporate governance practices and board performance. Kate has over 20 years' experience in corporate governance and strategy through her consulting work with the boards of client organisations, her directorships, and her previous involvement as a facilitator in the Company Directors’ Course offered by the Australian Institute of Company Directors.
Kate’s board experience includes directorships in Integrated Research Ltd, the South Australian TAB, Australian Central Credit Union Ltd, Festival City Broadcasters Ltd, Tech Project Pty Ltd and chairmanships of Saab Intelligent Transport Systems Ltd, Bassett Consulting Engineers and Accru Harris Orchard. She currently Chairs MGA Whittles Group Future Directions Committee.
A regular public speaker on governance issues, Kate was a committee member for the independent review of the governance of soccer in Australia as well as a member of the University of Adelaide’s Independent Selection Committee. She is currently a fellow of the Institute of Company Directors, and a member of the Law Society of South Australia.
Commencement date: 12/08/2005
Law Degree (University of Adelaide)
Stephen has more than 30 years’ experience as a legal practitioner including being a partner with the Adelaide law firm, Kelly & Co from 1988 to 2001. In that time he headed the firm’s Employment, Industrial Law and Superannuation Section. He was also responsible for managing much of Kelly & Co’s internal risk management functions. Stephen remains a Consultant to the firm.
Stephen is Chairman of Australian Timbers Ltd and Poly Products Co Pty Ltd. He was a director of Paragon Private Equity and its associated companies, a director of the McArthur Management Group of Companies and Chairman of Cavitus Pty Ltd.
Stephen is a former Deputy Chairman and Chairman of the Investment Committee of Non-Government Schools (NGS) Superannuation Fund, an industry fund with funds under management exceeding $5 billion. During his time at NGS the fund grew from $1.6 billion to more than $5 billion.
Stephen is also a former Chairman of the School Council of Westminster School Incorporated and is Chairman of the Investment Committee for the Westminster School Foundation.
Commencement date: 15/11/2006
Masters Degree in Applied Finance (Kaplan), Masters Degree in Business Administration (University of Adelaide), Bachelor of Accountancy (University of South Australia)
Dan has worked as a director, CFO or company secretary for a variety of companies in the construction, technology and financial services sectors. His current non-executive directorships include power industry supplier AEM Cores and ultrasound technology developer Cavitus Pty Ltd. Both companies are high growth, export focused businesses of whom sell globally into more than 30 countries.
Previously, Dan had spent six years in private equity as an Investment Manager with Paragon Private Equity, a $34m buyout and expansion capital fund, and spent five years working in London across various sectors in international financial reporting and project management roles.
Dan is a Chartered Accountant, Fellow of FINSIA and a certificated member of the Governance Institute of Australia.
Bachelor of Science, Business Administration and Corporate Finance (University of North Carolina)
Matthew Michalewicz has more than 20 years’ experience in starting and running high-growth tech companies, particularly in the areas of predictive analytics and optimisation software. He is currently the CEO of Complexica Pty Ltd, a provider of artificial intelligence software applications that help large organisations increase revenue, margin and customer engagement through automated analytics.
Matt has extensive experience as an international business executive specialising in start-ups, raising capital, technology commercialisation, sales and marketing strategy and execution, international expansion, corporate governance and mergers and acquisitions.
Prior to co-founding Complexica, he was the CEO of SolveIT Software Pty Ltd, a provider of artificial intelligence software for optimising complex supply chains. He grew that company from zero to 180 employees during 2005-12 while building revenue in excess of A$20 million per annum. The company was also named the third fastest growing in Australia by Deloitte in 2012.
He is a director on three boards: ComOps Ltd (ASX:COM), Prophecy International Ltd (ASX:PRO) and Complexica, and has served on numerous other boards throughout his career.
Matt was also named 2002 Alumnus of the Year for outstanding business achievements by the University of North Carolina. He completed a Company Director’s Course (CDC) at the Australian Institute of Company Directors.
He has also been awarded numerous prestigious awards throughout his career including Pearcey Foundation Entrepreneur of the Year, Ernst & Young Entrepreneur of the Year finalist, Forty under 40 by the Charlotte Business Journal and Entrepreneur of the Year by the Charlotte Chamber of Commerce.
Commencement date: 01/09/2017
Master of Business Administration—Australian Graduate School of Management (University of NSW) Bachelor of Medicine and Bachelor of Surgery (University of Witwatersrand, Johannesburg)
Glenn Haifer has over 30 years’ experience in the healthcare sector. He has successfully established four different businesses operating in primary medical services, histopathology and cosmetic medical services, which he has exited through sales to private equity firms and to an ASX listed company.
Glenn is an experienced company director. His current directorships include Sun Doctors, a health care organisation that employs 250 staff and contracting doctors and offers special interest medical services, and access to one of the largest private histopathology laboratories in Australia.
He is a Non-executive Director of Aurora Expeditions, an expedition company and travel agency that operates in remote areas of the world including the polar regions. He was also previously a Non-executive Director of BDS Vircon, a multinational engineering services business employing over 300 staff, which was sold to a US listed public company in October 2016.
In addition to his 20 years’ experience in general management of health care service delivery, Glenn has current roles as Medical Consultant to Apotex Pharmaceuticals and is the Australasian Medical Consultant to P&O/ Princess Cruises.
Glenn is a registered Australian Specialist Medical Practitioner, and a fellow of the College of Rural and Remote Medicine. He is a member of the Australian Institute of Company Directors, and was previously a member of the American Stock Exchange in New York.
Commencement date: 01/09/2017